Allergan Cash Flow Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Quarter Ending Jun 08 |
Quarter Ending Mar 08 |
Quarter Ending Dec 07 |
Quarter Ending Sep 07 |
Quarter Ending Jun 07 |
|
|---|---|---|---|---|---|
| Net Operating Cash Flow | 203.1 | 42.1 | 220.1 | 241.6 | 225.1 |
| Net Investing Cash Flow | (117.5) | (32.0) | (373.7) | (91.0) | (32.3) |
| Net Financing Cash Flow | (99.2) | (75.8) | (105.0) | 25.8 | (8.9) |
| Net Change in Cash | (14.4) | (53.3) | (255.4) | 184.7 | 185.5 |
| Depreciation & Amortization | 65.6 | 64.5 | 60.2 | 54.1 | 53.6 |
| Capital Expenditures | (37.3) | (28.4) | (68.2) | (24.6) | (26.8) |
| Cash Dividends Paid | (15.3) | (15.1) | (15.2) | (15.3) | (15.2) |
This data is provided as per license from EDGAR Online
